BioNTech seeking details on heart inflammation reports, says CEO

The CEO said reports appeared to be anecdotal

BioNTech is making the Pfizer Covid-19 vaccine. Credit: AFP Photo

German biotech startup BioNTech is seeking details of reports from Israel of cases of heart inflammation among people receiving the Covid-19 vaccine it is making with Pfizer, Chief executive Ugur Sahin said on Wednesday.

Read more: Israel examining heart inflammation cases in people who received Pfizer Covid shot

Sahin said the reports appeared to be anecdotal, and added that monitoring by public health authorities in countries like the United States or Germany showed no unusual incidence of such symptoms.

"We have no evidence until now of any accumulation of this heart muscle inflammation," Sahin told an online briefing hosted by Germany's foreign correspondents' association.

Deccan Herald is on WhatsApp Channels| Join now for Breaking News & Editor's Picks